Patel, Mallika P.
Woodring, Sarah
Randazzo, Dina M.
Friedman, Henry S.
Desjardins, Annick
Healy, Patrick
Herndon, James E. II
McSherry, Frances
Lipp, Eric S.
Miller, Elizabeth
Peters, Katherine B.
Affronti, Mary Lou https://orcid.org/0000-0003-4004-7834
Funding for this research was provided by:
Merck
Article History
Received: 6 May 2019
Accepted: 9 August 2019
First Online: 22 August 2019
Compliance with ethical standards
:
: All study processes involving human subjects were performed in accordance with the ethical standards of the institutional review board of the Duke University Medical Center. All study participants voluntarily provided written informed consent prior to study inclusion.
: Mary Lou Affronti has been supported by Eisai and Merck for investigator initiated clinical trials, served as an antiemetic expert advisory board member with Eisai for NEPA (2013–2014) and for Merck on an Advisory Expert Input forum (2017). Sarah Woodring, Annick Desjardins, Eric Lipp, and Elizabeth Miller received support from grant by Merck with their involvement during the conduct of the study. All other authors declare no conflict of interest at this time.